By HCPA Telehealth Advisory Team ·
We manage telehealth accreditation, prescribing setup, and e-health integration so you can focus on delivering targeted peptide therapies and growing your business.
A peptides telehealth service is a digital clinic model that lets practitioners consult, prescribe, and manage peptide therapies remotely through secure, government-approved telehealth platforms. Peptides — short chains of amino acids used for muscle growth, recovery, and anti-ageing — are now requested by hundreds of thousands of Australians daily. According to the Therapeutic Goods Administration (TGA), demand for regulated peptide products has grown steadily since 2020, making this one of Australia's fastest-expanding wellness categories.
This demand enables practitioners to build a recurring subscription model. Because patients need ongoing consultations and prescription renewals, telehealth peptide clinics can scale to millions in annual revenue without geographic limits. Additionally, HCPA's network of over 10,500 businesses demonstrates that the model works at scale across diverse clinical specialties.
You can reach more than 300,000 patients through secure teleconsultations. Australia's peptide market is expanding rapidly, with patients actively seeking telehealth access for muscle growth, recovery, and anti-ageing treatments. According to Australian Bureau of Statistics health data, telehealth adoption surged after 2020, and patient willingness to use remote consultations for specialist therapies has remained high.
Each patient spends approximately $250 per month on consultations, prescriptions, and personalised treatment plans. As a result, a clinic with 200 active patients generates roughly $50,000 in monthly recurring revenue. This predictable income stream comes from ongoing prescription management that patients willingly pay for because they receive tailored care.
| Active Patients | Avg. Monthly Spend | Monthly Revenue | Annual Revenue |
|---|---|---|---|
| 100 | $250 | $25,000 | $300,000 |
| 300 | $250 | $75,000 | $900,000 |
| 1,000 | $250 | $250,000 | $3,000,000 |
The subscription model means patients return monthly for consultations and prescription renewals, creating steady cash flow without geographic limits. Because peptide therapies typically require ongoing clinical oversight — dosage adjustments, blood-work reviews, and progress assessments — patients stay enrolled for extended periods. In contrast to one-off consultation models, this approach builds compounding revenue over time.
HCPA's setup process follows three structured steps that take you from initial assessment to a live, operational telehealth clinic. The goal is clear: you're fully registered, compliant, and seeing patients.
Throughout the process, HCPA's consultants handle the regulatory complexity so practitioners can focus on clinical care. Therefore, most clinics move from initial engagement to live operations significantly faster than self-managed setups.
Every HCPA engagement is backed by two written guarantees designed to remove financial risk from your telehealth setup. These guarantees apply from registration through to your first paying client.
The Setup Guarantee means that if your setup is not completed successfully, you receive a full refund and get to keep all the work completed. HCPA has three attempts to complete the setup. In other words, you pay nothing if the registration process fails — and you retain all documentation, policies, and frameworks already produced.
Once your business is operational, HCPA will work with you to secure your first paying client within 12 months. If HCPA does not deliver and you have met all your obligations, the team continues working at no cost until your first client is secured. This guarantee reflects HCPA's confidence in the peptide telehealth market demand.
The return on investment for a peptide telehealth service is typically realised within the first few months of operation, driven by high patient demand and recurring subscription revenue. Here is how HCPA accelerates that return:
Leading peptide clinics across Australia trust HCPA to deploy compliant, high-volume telehealth services. HCPA's client network has facilitated over $2.1 billion in revenue across telehealth and allied health sectors. Additionally, HCPA clients have collectively generated more than $50 million in telehealth peptide revenue — demonstrating that the model delivers measurable commercial outcomes when backed by proper compliance infrastructure.
Getting started is straightforward: tell HCPA your clinical model, and the team will respond within 24 hours to map your registration plan. From there, you can access Australia's $1B+ telemedicine peptide market and begin building your patient base immediately.
HCPA is a pioneer in peptide telehealth because its clients have generated over $50 million in telehealth peptide revenue to date. The organisation's track record includes guiding more than 10,500 businesses through healthcare registration and compliance processes.
"Telehealth is now a permanent feature of Australia's healthcare landscape — the practices that invest in proper compliance infrastructure today will capture the majority of patient demand tomorrow."
| Metric | Value |
|---|---|
| Annual peptide telehealth market (Australia) | $1B+ |
| Monthly patients accessing peptides | 300,000+ |
| Average monthly patient spend | $250 |
| HCPA client telehealth peptide revenue (total) | $50M+ |
| HCPA network facilitated revenue | $2.1B+ |
| Businesses in HCPA network | 10,500+ |
Australian practitioners can prescribe TGA-regulated peptides via telehealth, including those used for muscle recovery, anti-ageing, and metabolic support. The specific peptides available depend on the practitioner's prescribing authority and whether the peptide is listed on the Australian Register of Therapeutic Goods (ARTG) or accessed through the Special Access Scheme. HCPA maps each clinic's prescribing pathway during the initial setup step.
Most clinics move from initial engagement to live operations within weeks rather than months, because HCPA's expedited process reduces TGA/AHPRA timelines by up to 80%. The exact timeline depends on the complexity of the practitioner's clinical model and existing registrations. However, the three-step setup is designed to handle compliance, documentation, and launch in a compressed timeframe.
Yes. You must hold current AHPRA registration as a medical practitioner or nurse practitioner with appropriate prescribing rights. HCPA assesses your prescribing pathway and operational readiness during Step 1 of the setup process. The team then ensures your clinic structure, policies, and documentation align with AHPRA requirements and relevant state or territory telehealth regulations.
HCPA's Setup Guarantee covers this scenario. If the registration is not completed successfully after three attempts, you receive a full refund and keep all work completed — including policies, compliance documents, and framework materials. Terms and conditions apply, but the guarantee is designed to remove financial risk from the setup process entirely.
Yes. Peptide telehealth is compliant when the clinic meets TGA, AHPRA, and state-level telehealth requirements. According to the Australian Department of Health, telehealth is a recognised and supported model of care. HCPA's compliance framework covers clinical governance, IT infrastructure, data privacy, and prescribing protocols to ensure every clinic meets regulatory standards.
Let's discuss how we can help you achieve your business goals.
Call us at (03) 9084 7427Or Fill The Form Below